About City of Hope

City of Hope is an independent research and treatment center for diabetes, cancer and other life-threatening diseases. Bringing together the best in bench-to bedside research, City of Hope’s Arthur Riggs Diabetes & Metabolism Research Institute (AR-DMRI) is one of the world’s most comprehensive diabetes research programs.

City of Hope has a long and impressive history of groundbreaking discoveries in the field of diabetes spanning more than five decades since Rachmiel Levine, M.D., who discovered the role of insulin in glucose transport, launched diabetes research at City of Hope in the 1970s. The Institute is named for Arthur D. Riggs, Ph.D., another pioneer in the field famous for his work on synthesizing the first man-made gene and using synthetic genes to produce human insulin, now the standard of care for people with diabetes worldwide. The AR-DMRI is headed by Debbie Thurmond, Ph.D., a renowned research scientist, professor and founding chair of the Department of Molecular & Cellular Endocrinology.

City of Hope is also home to seminal National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) programs, such as the Human Islet Research Network (HIRN) and the Integrated Islet Distribution Program (IIDP), that lead the field of diabetes in diabetes research and translational potential.

City of Hope is located in Los Angeles, California, with community clinics throughout Southern California. It recently acquired Cancer Treatment Centers of America, extending its national reach. One of only 53 NCI-designated comprehensive cancer centers in the nation, it has been ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report for over 15 years. Founded in 1913, City of Hope is a pioneer in the fields of immunotherapy and clinical islet cell transplantation for diabetes, bone marrow transplantation and numerous breakthrough cancer drugs, many based on technology developed at the institution.

City of Hope’s commitment to Diversity, Equity and Inclusion

We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all of our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds and experiences to our work -- and that our teams align with the people we serve in order to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds and perspectives; this is reflected in our work and represented in our people.

Position Summary

A Postdoctoral Fellow position is available in Dr. Rupangi Vasavada’s lab in the Department of Translational Research and Cellular Therapeutics in the Arthur Riggs-Diabetes and Metabolism Research Institute at City of Hope. The lab is interested in understanding the pathophysiology of diabetes, assessing the role of extracellular vesicles in Type 1 and Type 2 diabetes as well as in aging. We are targeting specific biological pathways to enhance beta cell health, testing their effects from bench to bedside, to find therapeutics to combat the disease. The lab employs a combination of cellular and molecular techniques, mouse models and patient samples to assess these areas.

Basic education, experience and skills required for consideration:

· PhD or MD with a strong interest in the areas of islet biology, diabetes and/or extracellular vesicles.

· The candidate should be motivated to learning new techniques and become independent.

· To apply please include a brief interest statement as well as curriculum vitae

Additional Information:

· As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.

· For more information on Dr. Rupangi Vasavada please visit here: https://www.cityofhope.org/rupangi-vasavada